DIVITA CHARLES III (CHIEF EXECUTIVE OFFICER) sold 7.9% of their position (17.14K shares) of TELADOC HEALTH, INC. on the open market
Open‑market sale worth $130.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/11/2025ACC: 0001347535-25-000007
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Feb 2022
-17.14K
Net shares
Net seller
$130.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
39.16K acquired · 56.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+39.16K
Price / share
—
Trade value
—
% of position
21.9%
12/10/2025
179.01K→218.17K
Common Stock
Direct
Shares
−17.14K
Price / share
$7.63
Trade value
$130.84K
% of position
7.9%
12/11/2025
218.17K→201.04K
Total
Net shares
+22.02K
Net value
-$130.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2025 | M · Option Exercise | +39.16K | — | — | 21.9% | 179.01K | 218.17K |
| Common Stock Direct | 12/11/2025 | S · Sale | −17.14K | $7.63 | $130.84K | 7.9% | 218.17K | 201.04K |
| Total | +22.02K | -$130.84K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
39.16K shares
Shares
−39.16K
Strike price
Held after
234.96K
Exercisable
—
12/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock39.16K shares | 12/10/2025 | M · Option Exercise | −39.16K | — | 234.96K |